Home / 2012 (page 49)

Yearly Archives: 2012

Aliskiren No Help for Type 2 Patients

The ALTITUDE trial, which was prematurely halted, showed that when added to monotherapy with either an ACE inhibitor or an ARB, aliskiren (Tekturna) did not improve outcomes in patients with type 2 diabetes who had high cardiovascular and renal risk….

Read More »